Excessive sleepiness in children and teens
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study is looking at how common and how severe excessive daytime sleepiness (hypersomnia) is in children and teenagers with various sleep and developmental conditions. If your child has one of these conditions and struggles with sleepiness, they may be able to join to help doctors better understand and treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 6 and 17 years old.
- Child has a diagnosed sleep condition (like narcolepsy, hypersomnia, or sleep apnea).
- Family speaks and understands French.
- A parent or legal guardian can give consent.
- Child is covered by health insurance (like Social Security in France).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called solriamfetol to see if it safely reduces excessive daytime sleepiness in people with idiopathic hypersomnia. You may receive the study drug or a placebo, and your sleepiness levels will be monitored to see if the treatment helps.
This study tests a new medicine, HBS-301, for people with narcolepsy type 1 or type 2 who still have excessive daytime sleepiness. If you take other medications for sleepiness or mood, they must be stable for at least 3 months, and you cannot take some as-needed sleepiness medicines.
This study tests whether a new medication called samelisant can reduce extreme daytime sleepiness and sudden muscle weakness (cataplexy) in people with narcolepsy. If it works, it could offer a new treatment option for managing this sleep disorder.
This study tests a new drug called E2086 to see if it can help reduce daytime sleepiness and sudden muscle weakness in adults with narcolepsy. It involves two groups: people with cataplexy (type 1) and those without (type 2).
This study looks at whether people with narcolepsy or idiopathic hypersomnia have different patterns of daydreaming and mind-wandering compared to others with sleepiness but no clear diagnosis. It helps understand how certain brain states during sleep might affect waking thoughts.
This study looks at how narcolepsy or idiopathic hypersomnia affects thinking and cardiovascular health, and how usual treatment medications may change those outcomes. It may help researchers understand risks and benefits of common hypersomnia therapies.
Hear when a new Narcolepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.